2Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the manage- ment of aduhs with community-acquired pneumonia. Diagnosis, assess- ment of severity, antimicrobial therapy, and prevention [ J J. Am J Respir Crit Care Med,2001 ; 163 (7) : 1730-54.
6Allermann L, Poulsen OM. Inflammatory potential of dust from waste han- dling facilities measured as IL-8 secretion from lung epithelial cells in vitro [J]. Ann Occup Hyg,2000 ;44 (4) :259-69.
4Knta AE, Baum LL. C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes[J]. J Exp Med, 1986(164):321-329.
5Egenhofer C, Alsdorff K, Fehsel K, et al. Membrane-associated C-reactive protein on rat liver macrophages is synthesized within the macrophages, expressed as neo-C-reactive protein and bound through a C-reactive protein-specific membrance receptor[J]. Hepatology, 1993 ,(18): 1216-1224.
6Kolb BV, Puchtateudt N, Egenhofer C. Expression of membrance-associated C-reactive protein by human monocytes: indications for a selectin-like activity participating in adhersion[J]. Glycoconj J, 1995,12 (suppl 2):122-128.
7Subodh V, Chao-HW, Shu HL, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis[J]. Circulation, 2002,106(10):913.
8Leorid S, Saquib S, Hartzel VS, et al. C-reactive protein relaxes human vessels in vitro[J]. Arterioscl Thromb Vasc Bio, 2002,22(2):1865-1868.
9Gould JM, Weiser JN. Expression of C-reactive protein in the human respiratory tract[J]. Infect Immun, 2001,69(3):1747-1754.
10Dev D, Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease[J]. Respir Med, 1998,123(92):664-667.
